ATE341340T1 - Zusammensetzungen zur eröffnung der wasserkanäle und medizinische zusammensetzungen zur opthalmischer verwendung - Google Patents

Zusammensetzungen zur eröffnung der wasserkanäle und medizinische zusammensetzungen zur opthalmischer verwendung

Info

Publication number
ATE341340T1
ATE341340T1 AT00951907T AT00951907T ATE341340T1 AT E341340 T1 ATE341340 T1 AT E341340T1 AT 00951907 T AT00951907 T AT 00951907T AT 00951907 T AT00951907 T AT 00951907T AT E341340 T1 ATE341340 T1 AT E341340T1
Authority
AT
Austria
Prior art keywords
compositions
opener
water channels
opening water
medical
Prior art date
Application number
AT00951907T
Other languages
English (en)
Inventor
Shiro Mita
Naruhiro Ishida
Shin-Ichiro Hirai
Original Assignee
Santen Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Santen Pharmaceutical Co Ltd filed Critical Santen Pharmaceutical Co Ltd
Application granted granted Critical
Publication of ATE341340T1 publication Critical patent/ATE341340T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/4965—Non-condensed pyrazines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0048—Eye, e.g. artificial tears
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Emergency Medicine (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Materials For Medical Uses (AREA)
AT00951907T 1999-08-10 2000-08-09 Zusammensetzungen zur eröffnung der wasserkanäle und medizinische zusammensetzungen zur opthalmischer verwendung ATE341340T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP22676199 1999-08-10

Publications (1)

Publication Number Publication Date
ATE341340T1 true ATE341340T1 (de) 2006-10-15

Family

ID=16850211

Family Applications (1)

Application Number Title Priority Date Filing Date
AT00951907T ATE341340T1 (de) 1999-08-10 2000-08-09 Zusammensetzungen zur eröffnung der wasserkanäle und medizinische zusammensetzungen zur opthalmischer verwendung

Country Status (8)

Country Link
EP (1) EP1206942B1 (de)
AT (1) ATE341340T1 (de)
AU (1) AU6472400A (de)
DE (1) DE60031132T2 (de)
DK (1) DK1206942T3 (de)
ES (1) ES2273718T3 (de)
PT (1) PT1206942E (de)
WO (1) WO2001012225A1 (de)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20090214676A1 (en) 2005-04-30 2009-08-27 Tissuetech, Inc. Method for treating ocular demodex
US8128968B2 (en) 2007-08-29 2012-03-06 Tissuetech, Inc. Compositions and methods for treating Demodex infestations

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0451130A3 (en) * 1990-04-05 1992-08-05 Baltimore Biotech, Inc. Use of amiloride and other pyrazine derivatives for preventing or treating ocular neovascularization
JP3256997B2 (ja) * 1990-08-30 2002-02-18 千寿製薬株式会社 安定な水性製剤
JPH07126163A (ja) * 1993-10-08 1995-05-16 Theratech Inc 制御放出性ピロカルピン送達システム
US5698533A (en) * 1994-07-26 1997-12-16 Kang; Meng-Che Ophthalmic pharmaceutical composition
JPH09143064A (ja) * 1995-11-27 1997-06-03 Taisho Pharmaceut Co Ltd 眼精疲労改善用点眼液
JP3402613B2 (ja) * 1996-09-26 2003-05-06 ロート製薬株式会社 点眼剤
JP3090125B2 (ja) * 1997-08-26 2000-09-18 千寿製薬株式会社 ソフトコンタクトレンズ用の眼科用組成物、ソフトコンタクトレンズの濡れ増強方法およびテルペノイドの吸着抑制方法
JP4274593B2 (ja) * 1997-12-18 2009-06-10 ロート製薬株式会社 清涼化剤を含有するコンタクトレンズ用点眼剤
JP3621596B2 (ja) * 1998-01-23 2005-02-16 参天製薬株式会社 ペプチド及び医薬組成物

Also Published As

Publication number Publication date
EP1206942A1 (de) 2002-05-22
EP1206942B1 (de) 2006-10-04
WO2001012225A1 (en) 2001-02-22
PT1206942E (pt) 2007-01-31
ES2273718T3 (es) 2007-05-16
DE60031132T2 (de) 2007-08-23
DE60031132D1 (de) 2006-11-16
DK1206942T3 (da) 2007-02-05
EP1206942A4 (de) 2004-04-28
AU6472400A (en) 2001-03-13

Similar Documents

Publication Publication Date Title
EA200100589A1 (ru) Азабициклоалканы как модуляторы ccr5
EA200100588A1 (ru) Пиперидины как модуляторы ccr5
AP2003002915A0 (en) HIV protease inhibitors, compositions containing the same, their pharmaceutical uses and materials for their synthesis.
BR0213660A (pt) Composto, composição farmacêutica e método para tratar pacientes
PL354030A1 (en) Antipicornaviral compounds and compositions, their pharmaceutical uses, and materials for their synthesis
BR0310092A (pt) Combinação de compostos orgânicos
NO20030845D0 (no) Utvalgte fusjonerte pyrrolokarbazoler
BR0110703A (pt) Amida, composição farmacêutica que compreende um composto, compostos, utilização de compostos, processos para o tratamento profilático ou terapêutico de diabetes do tipo ii e para a preparação desses compostos
EA200301216A1 (ru) Замещенные хинуклидинами мультициклические гетероарилы для лечения заболевания
ATE433447T1 (de) Pyrimiidinverbindungen
NO990667D0 (no) Depeptid-benzamidin som kinogenase-inhibitor
AP2002002510A0 (en) Antipicornaviral compounds and compositions, their pharmaceutical uses, and materials for their sythesis.
ID26055A (id) Senyawa-senyawa hidroksidifenil eter
MY158159A (en) Novel fused pyrrolocarbazoles
SG149042A1 (en) Novel fused pyrrolocarbazoles
BRPI0409376A (pt) derivados de indeno como agentes farmacêuticos
TR200302288T2 (tr) Terapi için yeni bileşikler ve metotlar.
DE60116106D1 (de) Benzofuran derivate und ihre verwendung als antibakterielle wirkstoffe
ES2147973T3 (es) Estirenos alquilatados como profarmacos de inhibidores de cox-2.
DE60031132D1 (de) Zusammensetzungen zur eröffnung der wasserkanäle und medizinische zusammensetzungen zur opthalmischer verwendung
WO2004024077A3 (en) Novel composition and methods for the treatment of psoriasis
ATE527280T1 (de) Fluoreszentprotein und chromoprotein
PT937708E (pt) Derivados de sulfonamidas
PT1104419E (pt) Derivados de azabicicloheptano substituidos no azoto sua preparacao e utilizacao
DE59802890D1 (de) 3-Mercapto-2-alkyl-alkan-1-ole und ihre Anwendung als Duft- und Aromastoffe

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1206942

Country of ref document: EP

REN Ceased due to non-payment of the annual fee